Wells Fargo & Company Standard Biotools Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Standard Biotools Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 140,362 shares of LAB stock, worth $233,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,362

Previous 133,531 5.12%

Holding current value

$233,000

Previous $236,000 14.41%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.42 - $2.35 $9,700 - $16,052	6,831 Added 5.12%	140,362 $270,000
Q2 2024 Aug 13, 2024	BUY	$1.65 - $2.92 $201,834 - $357,186	122,324 Added 1091.5%	133,531 $236,000
Q1 2024 May 10, 2024	BUY	$1.87 - $2.78 $19,113 - $28,414	10,221 Added 1036.61%	11,207 $30,000
Q4 2023 Feb 09, 2024	BUY	$1.59 - $2.73 $62 - $106	39 Added 4.12%	986 $2,000
Q3 2023 Nov 13, 2023	BUY	$1.9 - $3.05 $121 - $195	64 Added 7.25%	947 $2,000
Q2 2023 Aug 15, 2023	BUY	$1.47 - $2.56 $22 - $38	15 Added 1.73%	883 $1,000
Q1 2023 May 12, 2023	BUY	$1.3 - $2.24 $9 - $15	7 Added 0.81%	868 $1,000
Q4 2022 Feb 13, 2023	BUY	$0.93 - $1.52 $14 - $24	16 Added 1.89%	861 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $1,303 - $2,441	-1,185 Reduced 58.37%	845 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.6 - $3.99 $24,364 - $60,759	-15,228 Reduced 88.24%	2,030 $3,000
Q1 2022 May 16, 2022	SELL	$2.8 - $3.96 $79,836 - $112,911	-28,513 Reduced 62.29%	17,258 $62,000
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $362,444 - $612,062	-99,847 Reduced 68.57%	45,771 $179,000
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $615,351 - $829,045	111,882 Added 331.64%	145,618 $960,000
Q2 2021 Aug 16, 2021	SELL	$4.35 - $6.35 $199,121 - $290,671	-45,775 Reduced 57.57%	33,736 $208,000
Q1 2021 May 13, 2021	SELL	$3.94 - $7.09 $402,660 - $724,583	-102,198 Reduced 56.24%	79,511 $359,000
Q4 2020 Feb 09, 2021	BUY	$5.45 - $8.65 $574,773 - $912,254	105,463 Added 138.32%	181,709 $1.09 Million
Q3 2020 Nov 05, 2020	SELL	$4.34 - $11.43 $81,748 - $215,295	-18,836 Reduced 19.81%	76,246 $566,000
Q2 2020 Aug 13, 2020	SELL	$1.85 - $5.29 $60,754 - $173,723	-32,840 Reduced 25.67%	95,082 $381,000
Q1 2020 May 14, 2020	BUY	$1.24 - $4.35 $158,623 - $556,460	127,922 New	127,922 $325,000

Others Institutions Holding LAB

# of Institutions

143

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Standard Biotools Inc. Transaction History